ID   S29A1_RAT               Reviewed;         457 AA.
AC   O54698;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 157.
DE   RecName: Full=Equilibrative nucleoside transporter 1 {ECO:0000303|PubMed:9353301};
DE            Short=rENT1 {ECO:0000303|PubMed:9353301};
DE   AltName: Full=Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter {ECO:0000303|PubMed:9353301};
DE            Short=Equilibrative NBMPR-sensitive nucleoside transporter {ECO:0000303|PubMed:9353301};
DE   AltName: Full=Nucleoside transporter, es-type;
DE   AltName: Full=Solute carrier family 29 member 1 {ECO:0000250|UniProtKB:Q99808};
GN   Name=Slc29a1 {ECO:0000312|RGD:61899}; Synonyms=Ent1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Jejunum;
RX   PubMed=9353301; DOI=10.1074/jbc.272.45.28423;
RA   Yao S.Y.M., Ng A.M.L., Muzyka W.R., Griffiths M., Cass C.E., Baldwin S.A.,
RA   Young J.D.;
RT   "Molecular cloning and functional characterization of
RT   nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei)
RT   equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat
RT   tissues.";
RL   J. Biol. Chem. 272:28423-28430(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11584005; DOI=10.1074/jbc.m107169200;
RA   Sundaram M., Yao S.Y., Ingram J.C., Berry Z.A., Abidi F., Cass C.E.,
RA   Baldwin S.A., Young J.D.;
RT   "Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-
RT   sensitive nucleoside transporter (hENT1) implicated in the cellular uptake
RT   of adenosine and anti-cancer drugs.";
RL   J. Biol. Chem. 276:45270-45275(2001).
RN   [4]
RP   TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   ILE-33; PHE-335 AND ASN-339.
RX   PubMed=17379602; DOI=10.1074/jbc.m701735200;
RA   Visser F., Sun L., Damaraju V., Tackaberry T., Peng Y., Robins M.J.,
RA   Baldwin S.A., Young J.D., Cass C.E.;
RT   "Residues 334 and 338 in transmembrane segment 8 of human equilibrative
RT   nucleoside transporter 1 are important determinants of inhibitor
RT   sensitivity, protein folding, and catalytic turnover.";
RL   J. Biol. Chem. 282:14148-14157(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=23639800; DOI=10.1124/jpet.113.203265;
RA   Klein D.M., Evans K.K., Hardwick R.N., Dantzler W.H., Wright S.H.,
RA   Cherrington N.J.;
RT   "Basolateral uptake of nucleosides by Sertoli cells is mediated primarily
RT   by equilibrative nucleoside transporter 1.";
RL   J. Pharmacol. Exp. Ther. 346:121-129(2013).
CC   -!- FUNCTION: Uniporter involved in the facilitative transport of
CC       nucleosides and nucleobases, and contributes to maintaining their
CC       cellular homeostasis (PubMed:9353301). Functions as a Na(+)-independent
CC       transporter (By similarity). Involved in the transport of nucleosides
CC       such as adenosine, thymidine and uridine (PubMed:23639800,
CC       PubMed:9353301). Also transports purine nucleobases (hypoxanthine,
CC       adenine, guanine) and pyrimidine nucleobases (thymine, uracil) (By
CC       similarity). Mediates basolateral nucleoside uptake into Sertoli cells,
CC       thereby regulating the transport of nucleosides in testis across the
CC       blood-testis barrier (PubMed:23639800). Regulates inosine levels in
CC       brown adipocytes tissues (BAT) and extracellular inosine levels, which
CC       controls BAT-dependent energy expenditure (By similarity).
CC       {ECO:0000250|UniProtKB:Q99808, ECO:0000269|PubMed:23639800,
CC       ECO:0000269|PubMed:9353301}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine(in) = adenosine(out); Xref=Rhea:RHEA:75343,
CC         ChEBI:CHEBI:16335; Evidence={ECO:0000269|PubMed:17379602};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanosine(in) = guanosine(out); Xref=Rhea:RHEA:75371,
CC         ChEBI:CHEBI:16750; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=inosine(in) = inosine(out); Xref=Rhea:RHEA:75375,
CC         ChEBI:CHEBI:17596; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridine(out) = uridine(in); Xref=Rhea:RHEA:71519,
CC         ChEBI:CHEBI:16704; Evidence={ECO:0000269|PubMed:23639800};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=thymidine(in) = thymidine(out); Xref=Rhea:RHEA:75363,
CC         ChEBI:CHEBI:17748; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cytidine(in) = cytidine(out); Xref=Rhea:RHEA:75367,
CC         ChEBI:CHEBI:17562; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenine(out) = adenine(in); Xref=Rhea:RHEA:71523,
CC         ChEBI:CHEBI:16708; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanine(out) = guanine(in); Xref=Rhea:RHEA:71531,
CC         ChEBI:CHEBI:16235; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=thymine(out) = thymine(in); Xref=Rhea:RHEA:71527,
CC         ChEBI:CHEBI:17821; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uracil(in) = uracil(out); Xref=Rhea:RHEA:69404,
CC         ChEBI:CHEBI:17568; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hypoxanthine(out) = hypoxanthine(in); Xref=Rhea:RHEA:71515,
CC         ChEBI:CHEBI:17368; Evidence={ECO:0000250|UniProtKB:Q99808};
CC   -!- ACTIVITY REGULATION: Transport activity is sensitive to low
CC       concentrations of the inhibitor nitrobenzylmercaptopurine riboside
CC       (NBMPR). {ECO:0000269|PubMed:23639800, ECO:0000269|PubMed:9353301}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.4 uM for adenosine {ECO:0000269|PubMed:17379602};
CC         Vmax=530 pmol/min/mg enzyme {ECO:0000269|PubMed:17379602};
CC   -!- SUBUNIT: Identified in a complex with STOM.
CC       {ECO:0000250|UniProtKB:Q99808}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:23639800}; Multi-pass membrane protein
CC       {ECO:0000305}. Apical cell membrane {ECO:0000250|UniProtKB:Q99808};
CC       Multi-pass membrane protein {ECO:0000305}. Cell membrane
CC       {ECO:0000269|PubMed:11584005}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Localized to the basolateral membrane of Sertoli
CC       cells. {ECO:0000269|PubMed:23639800}.
CC   -!- TISSUE SPECIFICITY: Expressed in jejunum, liver and lung
CC       (PubMed:9353301). Expressed in testis at the blood-testis barrier (at
CC       protein level) (PubMed:23639800). Expressed in ventricular myocytes (at
CC       protein level) (PubMed:11584005). Expressed in kidney
CC       (PubMed:23639800). {ECO:0000269|PubMed:11584005,
CC       ECO:0000269|PubMed:23639800, ECO:0000269|PubMed:9353301}.
CC   -!- DOMAIN: Cys-415 near TM10 is a major determinant of nucleobase
CC       transport activity. {ECO:0000250|UniProtKB:Q99808}.
CC   -!- SIMILARITY: Belongs to the SLC29A/ENT transporter (TC 2.A.57) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF015304; AAB88049.1; -; mRNA.
DR   EMBL; BC078789; AAH78789.1; -; mRNA.
DR   RefSeq; NP_113872.1; NM_031684.2.
DR   RefSeq; XP_006244622.1; XM_006244560.2.
DR   RefSeq; XP_006244623.1; XM_006244561.2.
DR   RefSeq; XP_006244624.1; XM_006244562.3.
DR   RefSeq; XP_006244625.1; XM_006244563.3.
DR   RefSeq; XP_017452108.1; XM_017596619.1.
DR   AlphaFoldDB; O54698; -.
DR   SMR; O54698; -.
DR   STRING; 10116.ENSRNOP00000026831; -.
DR   BindingDB; O54698; -.
DR   ChEMBL; CHEMBL4604; -.
DR   DrugCentral; O54698; -.
DR   TCDB; 2.A.57.1.3; the equilibrative nucleoside transporter (ent) family.
DR   GlyCosmos; O54698; 3 sites, No reported glycans.
DR   GlyGen; O54698; 3 sites.
DR   iPTMnet; O54698; -.
DR   PhosphoSitePlus; O54698; -.
DR   jPOST; O54698; -.
DR   PaxDb; 10116-ENSRNOP00000026831; -.
DR   Ensembl; ENSRNOT00000108087.1; ENSRNOP00000082743.1; ENSRNOG00000019752.6.
DR   Ensembl; ENSRNOT00055012311; ENSRNOP00055009762; ENSRNOG00055007373.
DR   Ensembl; ENSRNOT00060034685; ENSRNOP00060028482; ENSRNOG00060019889.
DR   Ensembl; ENSRNOT00065042968; ENSRNOP00065035168; ENSRNOG00065024920.
DR   GeneID; 63997; -.
DR   KEGG; rno:63997; -.
DR   UCSC; RGD:61899; rat.
DR   AGR; RGD:61899; -.
DR   CTD; 2030; -.
DR   RGD; 61899; Slc29a1.
DR   eggNOG; KOG1479; Eukaryota.
DR   GeneTree; ENSGT00950000182898; -.
DR   HOGENOM; CLU_021611_6_0_1; -.
DR   InParanoid; O54698; -.
DR   OMA; KIMFINS; -.
DR   OrthoDB; 517168at2759; -.
DR   PhylomeDB; O54698; -.
DR   Reactome; R-RNO-83936; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane.
DR   Reactome; R-RNO-9748787; Azathioprine ADME.
DR   Reactome; R-RNO-9755088; Ribavirin ADME.
DR   PRO; PR:O54698; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000019752; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0015207; F:adenine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015212; F:cytidine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015208; F:guanine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005326; F:neurotransmitter transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005337; F:nucleoside transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015211; F:purine nucleoside transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015389; F:pyrimidine- and adenosine-specific:sodium symporter activity; ISS:UniProtKB.
DR   GO; GO:0015210; F:uracil transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015213; F:uridine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015853; P:adenine transport; ISS:UniProtKB.
DR   GO; GO:0032238; P:adenosine transport; ISS:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0015861; P:cytidine transport; ISS:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:1903716; P:guanine transmembrane transport; ISO:RGD.
DR   GO; GO:0035344; P:hypoxanthine transport; ISO:RGD.
DR   GO; GO:0035340; P:inosine transport; ISS:UniProtKB.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0001504; P:neurotransmitter uptake; ISO:RGD.
DR   GO; GO:0015851; P:nucleobase transport; ISS:UniProtKB.
DR   GO; GO:1901642; P:nucleoside transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0015858; P:nucleoside transport; IDA:UniProtKB.
DR   GO; GO:1904823; P:purine nucleobase transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0015860; P:purine nucleoside transmembrane transport; ISO:RGD.
DR   GO; GO:1904082; P:pyrimidine nucleobase transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0072531; P:pyrimidine-containing compound transmembrane transport; ISO:RGD.
DR   GO; GO:0035364; P:thymine transport; ISO:RGD.
DR   GO; GO:1903791; P:uracil transmembrane transport; ISO:RGD.
DR   GO; GO:0015862; P:uridine transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR034764; ENT1/ENT2.
DR   InterPro; IPR002259; Eqnu_transpt.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   NCBIfam; TIGR00939; 2a57; 1.
DR   PANTHER; PTHR10332; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; 1.
DR   PANTHER; PTHR10332:SF9; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; 1.
DR   Pfam; PF01733; Nucleoside_tran; 1.
DR   PIRSF; PIRSF016379; ENT; 1.
DR   PRINTS; PR01130; DERENTRNSPRT.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..457
FT                   /note="Equilibrative nucleoside transporter 1"
FT                   /id="PRO_0000209339"
FT   TOPO_DOM        1..12
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        13..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..82
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        83..107
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        108..111
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        112..130
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        131..138
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        139..157
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        158..174
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        175..199
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        200..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..227
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        228..291
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        292..311
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        312..323
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        324..343
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        344..360
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        361..379
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        380..394
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        395..414
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        415..432
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        433..453
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        454..457
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          255..275
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            415
FT                   /note="Essential for nucleobase transport"
FT                   /evidence="ECO:0000250|UniProtKB:Q99808"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99808"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        48
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         33
FT                   /note="I->M: Increase in the sensitivities to dipyridamole
FT                   and dilazep."
FT                   /evidence="ECO:0000269|PubMed:17379602"
FT   MUTAGEN         335
FT                   /note="F->Y: Increase in the transport capacity for
FT                   adenosine but no change in substrate affinity. Increase in
FT                   the sensitivities to dipyridamole and dilazep."
FT                   /evidence="ECO:0000269|PubMed:17379602"
FT   MUTAGEN         339
FT                   /note="N->C: Increase in the sensitivities to dipyridamole
FT                   and dilazep."
FT                   /evidence="ECO:0000269|PubMed:17379602"
SQ   SEQUENCE   457 AA;  50017 MW;  A9DDF4F0D7F8D70A CRC64;
     MTTSHQPQDR YKAVWLIFFV LGLGTLLPWN FFITATQYFT SRLNTSQNIS LVTNQSCEST
     EALADPSVSL PARSSLSAIF NNVMTLCAML PLLIFTCLNS FLHQKVSQSL RILGSLLAIL
     LVFLVTATLV KVQMDALSFF IITMIKIVLI NSFGAILQAS LFGLAGVLPA NYTAPIMSGQ
     GLAGFFTSVA MICAVASGSK LSESAFGYFI TACAVVILAI LCYLALPWME FYRHYLQLNL
     AGPAEQETKL DLISEGEEPR GGREESGVPG PNSLPANRNQ SIKAILKSIW VLALSVCFIF
     TVTIGLFPAV TAEVESSIAG TSPWKNCYFI PVACFLNFNV FDWLGRSLTA ICMWPGQDSR
     WLPVLVACRV VFIPLLMLCN VKQHHYLPSL FKHDVWFITF MAAFAFSNGY LASLCMCFGP
     KKVKPAEAET AGNIMSFFLC LGLALGAVLS FLLRALV
//
